Conatus Capital Management’s St Jude Medical STJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q2
Sell
-1,307,613
Closed -$71.9M 31
2016
Q1
$71.9M Sell
1,307,613
-314,580
-19% -$17.1M 4.66% 10
2015
Q4
$100M Buy
1,622,193
+171,005
+12% +$10.8M 6.59% 5
2015
Q3
$91.6M Buy
1,451,188
+66,974
+5% +$4.78M 5.79% 9
2015
Q2
$101M Buy
1,384,214
+67,445
+5% +$4.87M 6.16% 6
2015
Q1
$86.1M Buy
+1,316,769
New +$87.6M 5.45% 9

Other funds holding STJ

Conatus Capital Management's STJ Position: Q2 2016 in Review

Conatus Capital Management sold out of St Jude Medical (STJ) in Q2 2016, closing a stake of 1,307,613 shares — an estimated $71.9M sold.

Conatus Capital Management first reported a position in STJ in Q1 2015 and held it in 5 quarters. The position peaked at $101M in Q2 2015. 615 funds tracked by Wall St. Rank hold STJ as of Q2 2016.

  • Conatus Capital Management reported no remaining St Jude Medical position as of Q2 2016 after selling out during the quarter.
  • Conatus Capital Management sold 1,307,613 St Jude Medical shares in Q2 2016, an estimated $71.9M.
  • Conatus Capital Management first reported a position in St Jude Medical in Q1 2015 and held it in 5 quarters.
  • Conatus Capital Management's St Jude Medical position peaked at $101M in Q2 2015.
  • 615 funds tracked by Wall St. Rank held St Jude Medical as of Q2 2016.

Based on Conatus Capital Management's 13F filing for Q2 2016, filed 15 Aug 2016.